Serum Institute of India Pvt. Ltd.
Asia, Maharashtra, India, Pune'%3e%3ccircle r='20' fill='%23008'/%3e%3ccircle r='17.5' fill='%23fff'/%3e%3ccircle r='3.5' fill='%23008'/%3e%3cg id='d'%3e%3cg id='c'%3e%3cg id='b'%3e%3cg id='a' fill='%23008'%3e%3ccircle r='.875' transform='rotate(7.5 -8.75 133.5)'/%3e%3cpath d='M0 17.5.6 7 0 2l-.6 5L0 17.5z'/%3e%3c/g%3e%3cuse xlink:href='%23a' transform='rotate(15)'/%3e%3c/g%3e%3cuse xlink:href='%23b' transform='rotate(30)'/%3e%3c/g%3e%3cuse xlink:href='%23c' transform='rotate(60)'/%3e%3c/g%3e%3cuse xlink:href='%23d' transform='rotate(120)'/%3e%3cuse xlink:href='%23d' transform='rotate(-120)'/%3e%3c/g%3e%3c/svg%3e)
Description
Serum Institute is vaccine manufacturer by number of doses produced.
Investor Profile
Serum Institute of India Pvt. Ltd. has backed more than 5 startups, with 2 new investments in the last 12 months alone. The firm has led 2 rounds, about 40% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Denmark, India.
- Strong thematic focus on Biotechnology, Medical, Genetics.
- Led 1 rounds in the past year.
Stage Focus
- Series A (40%)
- Series C (20%)
- Series B (20%)
- Series Unknown (20%)
Country Focus
- United States (60%)
- Denmark (20%)
- India (20%)
Industry Focus
- Biotechnology
- Medical
- Genetics
- Health Care
- Clinical Trials
- Health Diagnostics
- Therapeutics
- Biopharma
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
